Alternative sources of pluripotent stem cells: altered nuclear transfer
- PMID: 18181941
- PMCID: PMC6495280
- DOI: 10.1111/j.1365-2184.2008.00484.x
Alternative sources of pluripotent stem cells: altered nuclear transfer
Abstract
Altered nuclear transfer (ANT) is one of several methods that have been suggested for obtaining pluripotent stem cells without destroying human embryos. ANT proposes to alter the nucleus of a somatic cell and/or the cytoplasm of an enucleated oocyte such that when the two are combined, they do not produce a zygote, but rather they form a cell capable of producing pluripotent stem cells without being an embryo. The ANT proposal raises the serious question of whether it is possible to know with confidence that this procedure generates a non-embryo, rather than merely an embryo with a deficiency. Here I address the question of how embryos can be distinguished from non-embryos using scientific criteria and apply these criteria to the two forms of ANT proposed thus far: ANT combined with oocyte-assisted reprogramming (ANT-OAR) or with gene deletion (ANT-GD). I propose that the first globally coordinated event in human development, the formation of trophoblast and inner cell mass (ICM) lineages via Cdx2-Oct3/4 mutual cross-repression, is the earliest act of the embryo qua embryo; it is an operation intrinsic to an embryo as such, and entities lacking the power (potentia) for such an act cannot be considered embryos. Thus, I will argue that formation of trophoblast-ICM lineages is a both necessary and sufficient criterion for determining whether ANT produces an embryo or a non-embryonic entity.
Figures

Similar articles
-
Ethics and embryonic stem cell research: altered nuclear transfer as a way forward.BioDrugs. 2007;21(2):79-83. doi: 10.2165/00063030-200721020-00002. BioDrugs. 2007. PMID: 17402791
-
The flawed scientific basis of the altered nuclear transfer-oocyte assisted reprogramming (ANT-OAR) proposal.Stem Cell Rev. 2007 Jan;3(1):60-5. doi: 10.1007/s12015-007-0014-6. Stem Cell Rev. 2007. PMID: 17873382
-
Human trophectoderm cells are not yet committed.Hum Reprod. 2013 Mar;28(3):740-9. doi: 10.1093/humrep/des432. Epub 2012 Dec 19. Hum Reprod. 2013. PMID: 23257394
-
Parthenotes as a source of embryonic stem cells.Cell Prolif. 2008 Feb;41 Suppl 1(Suppl 1):20-30. doi: 10.1111/j.1365-2184.2008.00485.x. Cell Prolif. 2008. PMID: 18181942 Free PMC article. Review.
-
Uncovering the true identity of naïve pluripotent stem cells.Trends Cell Biol. 2013 Sep;23(9):442-8. doi: 10.1016/j.tcb.2013.04.004. Epub 2013 May 17. Trends Cell Biol. 2013. PMID: 23685019 Review.
Cited by
-
Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.Stem Cells Dev. 2010 Aug;19(8):1121-9. doi: 10.1089/scd.2009.0482. Stem Cells Dev. 2010. PMID: 20397928 Free PMC article. Review.
-
Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.Am J Pathol. 2010 Oct;177(4):2011-21. doi: 10.2353/ajpath.2010.091245. Epub 2010 Aug 19. Am J Pathol. 2010. PMID: 20724594 Free PMC article.
-
The importance of stem cell engineering in head and neck oncology.Biotechnol Lett. 2016 Oct;38(10):1665-72. doi: 10.1007/s10529-016-2163-7. Epub 2016 Jun 24. Biotechnol Lett. 2016. PMID: 27341837 Free PMC article. Review.
-
Musings on genome medicine: is there hope for ethical and safe stem cell therapeutics?Genome Med. 2009 Jul 14;1(7):70. doi: 10.1186/gm70. Genome Med. 2009. PMID: 19638185 Free PMC article.
-
Totipotency, pluripotency and nuclear reprogramming.Adv Biochem Eng Biotechnol. 2009;114:185-99. doi: 10.1007/10_2008_45. Adv Biochem Eng Biotechnol. 2009. PMID: 19343304 Free PMC article. Review.
References
-
- Arkes H, Austriaco NP, Berg T, Brugger EC, Cameron NM, Capizzi J, Condic ML, Condic SB, Fitzgerald KT, Flannery K, Furton EJ, George RP, George T, Gomez‐Lobo A, Grisez G, Grompe M, Haas JM, Hamerton‐Kelly R, Harvey JC, Hoehner PJ, Hurlbut WB, Kilner JF, Lee P, May WE, Miranda G, Mitchell CB, Myers JJ, Oleson C, Pacholczyk T, Ryan PF, Saunders WL, Stevens D, Swetland SW, Whelan ME, Williams T (2005) Production of pluripotent stem cells by oocyte‐assisted reprogramming: joint statement with signatories. Natl. Cathol. Bioeth. Q. 5, 579–583. - PubMed
-
- Boheler KR, Tarasov KV (2006) SAGE analysis to identify embryonic stem cell‐predominant transcripts. Methods Mol. Biol. 329, 195–221. - PubMed
-
- Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, Li Y, Xu C, Fang R, Guegler K, Rao MS, Mandalam R, Lebkowski J, Stanton LW (2004) Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 22, 707–716. - PubMed
-
- Chung Y, Klimanskaya I, Becker S, Marh J, Lu SJ, Johnson J, Meisner L, Lanza R (2006) Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216–219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources